Cite
Rusnati M, Urbinati C, Bonifacio S, et al. Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action. Pharmaceuticals (Basel). 2010;3(4):1241-1278doi: 10.3390/ph3041241.
Rusnati, M., Urbinati, C., Bonifacio, S., Presta, M., & Taraboletti, G. (2010). Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action. Pharmaceuticals (Basel, Switzerland), 3(4), 1241-1278. https://doi.org/10.3390/ph3041241
Rusnati, Marco, et al. "Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action." Pharmaceuticals (Basel, Switzerland) vol. 3,4 (2010): 1241-1278. doi: https://doi.org/10.3390/ph3041241
Rusnati M, Urbinati C, Bonifacio S, Presta M, Taraboletti G. Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action. Pharmaceuticals (Basel). 2010 Apr 23;3(4):1241-1278. doi: 10.3390/ph3041241. PMID: 27713299; PMCID: PMC4034032.
Copy
Download .nbib